Last reviewed · How we verify
COPE
COPE is a Small molecule drug developed by Gilead Sciences. It is currently FDA-approved. Also known as: Copegus®, Ribavirin.
At a glance
| Generic name | COPE |
|---|---|
| Also known as | Copegus®, Ribavirin |
| Sponsor | Gilead Sciences |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors (NA)
- Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain (NA)
- Impact of a Mindfulness Intervention on Infertile Women Undergoing Assisted Reproductive Technique Treatments (NA)
- Well-Being After Breast Cancer Surgery (NA)
- Adaptation and RCT of Written Exposure Therapy for Adolescents (NA)
- V-CARE (Virtual Care After REsuscitation) (NA)
- Biomolecular Characteristics of Reminder-Focused Positive-Psychiatry (NA)
- Mindfulness-Based Psychoeducation for Women With Gynecological Cancer (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- COPE CI brief — competitive landscape report
- COPE updates RSS · CI watch RSS
- Gilead Sciences portfolio CI
Frequently asked questions about COPE
What is COPE?
COPE is a Small molecule drug developed by Gilead Sciences.
Who makes COPE?
COPE is developed and marketed by Gilead Sciences (see full Gilead Sciences pipeline at /company/gilead).
Is COPE also known as anything else?
COPE is also known as Copegus®, Ribavirin.
What development phase is COPE in?
COPE is FDA-approved (marketed).
Related
- Manufacturer: Gilead Sciences — full pipeline
- Also known as: Copegus®, Ribavirin